SCHEMBL6370907

SCHEMBL6370907

CCOc1ccc([N+](=O)[O-])c(N2CCN(C(=O)O)CC2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 13/20 0.53
RECQL P46063 1/20 0.53
ALDH1A1 P00352 10/20 0.51
LMNA P02545 4/20 0.50
CYP2C9 P11712 2/20 0.50
CYP2C19 P33261 2/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
SMN1; SMN2 Q16637 4/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
GAA P10253 1/20 0.49
HPGD P15428 1/20 0.49
ENPP2 Q13822 2/20 0.47
GPR174 Q9BXC1 2/20 0.47
MEN1 O00255 1/20 0.46
CYP1A2 P05177 1/20 0.46
KMT2A Q03164 1/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6370911 1.00 MAPT (0.53) MAPTRECQLALDH1A1LMNACYP2C9
SCHEMBL5097945 0.84 MAPT (0.59) MAPTALDH1A1LMNACYP2C19NPSR1
SCHEMBL7259673 0.81 MAPT (0.56) MAPTRECQLALDH1A1LMNACYP2C19
SCHEMBL6377084 0.81 LMNA (0.58) MAPTALDH1A1LMNACYP2C9CYP2C19
SCHEMBL6371342 0.80 MAPT (0.46) MAPTALDH1A1LMNACYP2C9CYP2C19
SCHEMBL4137101 0.78 L3MBTL1 (0.54) MAPTALDH1A1LMNANPSR1SMN1; SMN2
SCHEMBL22471138 0.77 MAPT (0.62) MAPTRECQLALDH1A1LMNANPSR1
SCHEMBL6629188 0.76 GPR119 (0.50) MAPTALDH1A1LMNAENPP2
SCHEMBL4526192 0.74 GRM5 (0.67) MAPTALDH1A1LMNANPSR1SMN1; SMN2
SCHEMBL27691387 0.73 MAPT (0.56) MAPTALDH1A1LMNACYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050250816-A1 Positive allosteric modulators of the nicotinic acetylcholine receptor PFIZER INC 2005-11-10 US disclosed
US-20040254373-A1 Positive allosteric modulators of the nicotinic acetylcholine receptor PFIZER INC 2004-12-16 US disclosed
US-20040249150-A1 Positive allosteric modulators of the nicotinic acetylcholine receptor PFIZER INC 2004-12-09 US disclosed
US-20030236287-A1 Positive allosteric modulators of the nicotinic acetylcholine receptor PHARMACIA & UPJOHN COMPANY 2003-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040254373-A1 Positive allosteric modulators of the nicotinic acetylcholine receptor CHRNA1, CHRNB1, CHRM1 MAPT 1550/4885RECQL 1705/4885ALDH1A1 2007/4885
US-20030236287-A1 Positive allosteric modulators of the nicotinic acetylcholine receptor CHRNA1, CHRNB1, CHRM1 MAPT 1550/4885RECQL 1705/4885ALDH1A1 2007/4885
US-20040249150-A1 Positive allosteric modulators of the nicotinic acetylcholine receptor CHRNA1, CHRNB1, CHRM1 MAPT 1550/4885RECQL 1705/4885ALDH1A1 2007/4885
US-20050250816-A1 Positive allosteric modulators of the nicotinic acetylcholine receptor CHRNA7, CHRNA1, CHRNA5 MAPT 1395/4885RECQL 1693/4885ALDH1A1 2742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.